These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 23574151)

  • 1. NET-NET: are norepinephrine transport inhibitors a potentially useful therapy for vasovagal syncope?
    Roukoz H; Benditt DG
    J Cardiovasc Electrophysiol; 2013 Jul; 24(7):804-5. PubMed ID: 23574151
    [No Abstract]   [Full Text] [Related]  

  • 2. Norepinephrine transport inhibition for treatment of vasovagal syncope.
    Sheldon RS; Ritchie D; McRae M; Raj S
    J Cardiovasc Electrophysiol; 2013 Jul; 24(7):799-803. PubMed ID: 23444896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological norepinephrine transporter inhibition for the prevention of vasovagal syncope in young and adult subjects: A systematic review and meta-analysis.
    Lei LY; Raj SR; Sheldon RS
    Heart Rhythm; 2020 Jul; 17(7):1151-1158. PubMed ID: 32151742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the sympathetic nervous system in vasovagal syncope and rationale for beta-blockers and norepinephrine transporter inhibitors.
    Márquez MF; Gómez-Flores JR; González-Hermosillo JA; Ruíz-Siller TJ; Cárdenas M
    Medwave; 2016 Dec; 16(Suppl4):e6824. PubMed ID: 28055999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norepinephrine transporter inhibition prevents tilt-induced pre-syncope.
    Schroeder C; Birkenfeld AL; Mayer AF; Tank J; Diedrich A; Luft FC; Jordan J
    J Am Coll Cardiol; 2006 Aug; 48(3):516-22. PubMed ID: 16875978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent postural vasovagal syncope: sympathetic nervous system phenotypes.
    Vaddadi G; Guo L; Esler M; Socratous F; Schlaich M; Chopra R; Eikelis N; Lambert G; Trauer T; Lambert E
    Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):711-8. PubMed ID: 21844155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasovagal syncope: an update on the latest pharmacological therapies.
    Schleifer JW; Shen WK
    Expert Opin Pharmacother; 2015 Mar; 16(4):501-13. PubMed ID: 25534874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of vasovagal syncope (nonpharmacologic therapy and pharmacotherapy)].
    Mitro P
    Vnitr Lek; 2000 Dec; 46(12):861-8. PubMed ID: 11214367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-adrenergic receptor blockers and the treatment of vasovagal syncope: more nails in the coffin!
    Mathias CJ
    Clin Sci (Lond); 2006 Sep; 111(3):189-91. PubMed ID: 16848762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vasovagal syncope. Management with propanthelin bromide].
    Corbalá Fuentes C; Pacheco Ureña A; Pedraza Ibarra S; Gárate Ureña JA; Manzano Miranda L; Carrillo Camacho A; Haro García L
    Arch Inst Cardiol Mex; 1997; 67(3):227-30. PubMed ID: 9412436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe cardioinhibitory vasovagal syncope in sleep and supine posture.
    Xu Z; Bower S; Seneviratne U
    Epileptic Disord; 2014 Mar; 16(1):101-6. PubMed ID: 24556476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A refractory case of vasovagal syncope treated with theophylline.
    Moore A; Close JC; Jackson SH
    Clin Auton Res; 2003 Aug; 13(4):293-4. PubMed ID: 12955555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midodrine for the treatment of vasovagal syncope (simple faint).
    Stewart JM
    J Pediatr; 2006 Dec; 149(6):740-2. PubMed ID: 17137884
    [No Abstract]   [Full Text] [Related]  

  • 14. Predicting the effectiveness of beta-blocker therapy in vasovagal syncope.
    Kapoor JR
    J Am Coll Cardiol; 2008 Jun; 51(24):2372; author reply 2372-3. PubMed ID: 18549925
    [No Abstract]   [Full Text] [Related]  

  • 15. Norepinephrine transporter inhibition alters the hemodynamic response to hypergravitation.
    Strempel S; Schroeder C; Hemmersbach R; Boese A; Tank J; Diedrich A; Heer M; Luft FC; Jordan J
    J Appl Physiol (1985); 2008 Mar; 104(3):756-60. PubMed ID: 18187607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of recurrent neurocardiogenic syncope with cardiac inhibitors with ipratropium bromide].
    Friederich HC; Michaelsen J; Hesse C; Schellberg D; Schwab M; Herzog W
    Z Kardiol; 2004 Jun; 93(6):479-85. PubMed ID: 15252742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical observation of irbesartan in treatment of vasovagal syncope.
    Han Y; Lü XY; Jiang WL; Yang YM; Chen TZ
    Chin Med Sci J; 2005 Mar; 20(1):15. PubMed ID: 15844305
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral disopyramide in the treatment of recurrent neurocardiogenic syncope.
    Bhaumick SK; Morgan S; Mondal BK
    Int J Clin Pract; 1997; 51(5):342. PubMed ID: 9489103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norepinephrine transporter function and human cardiovascular disease.
    Schroeder C; Jordan J
    Am J Physiol Heart Circ Physiol; 2012 Dec; 303(11):H1273-82. PubMed ID: 23023867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Meta-analysis of beta-adrenoceptor blockers for the treatment of vasovagal syncope].
    Liao Y; Li XY; Zhang YW; Du JB
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 40(6):603-9. PubMed ID: 19088832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.